Speaker illustration

Doctor Maximilian Lobmeyer

Bayer AG, Wuppertal (Germany)

Metabolism and pharmacokinetic drug interaction profile of vericiguat, a soluble guanylate cyclase stimulator

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

This platform is supported by

logo Novo Nordisk